Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Joana Barbosa, Juliana Faria, Odília Queirós, Roxana Moreira, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2016) Comparative metabolism of tramadol and tapentadol: a toxicological perspective. Drug Metabolism Reviews 48:4, pages 577-592.
Read now
Read now
Michael J Brennan. (2013) Update on prescription extended-release opioids and appropriate patient selection. Journal of Multidisciplinary Healthcare 6, pages 265-280.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Craig T Hartrick. (2012) Noradrenergic reuptake inhibition in the treatment of pain. Expert Opinion on Investigational Drugs 21:12, pages 1827-1834.
Read now
Read now
Craig T Hartrick, Robert J Gatchel & Sean Conroy. (2012) Identification and management of pain medication abuse and misuse: current state and future directions. Expert Review of Neurotherapeutics 12:5, pages 601-610.
Read now
Read now
Articles from other publishers (17)
Alessandra Oliveira Silva, Danielle Aparecida de Oliveira Marrafon, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres & Marília Gabriella Alves Goulart Pereira. (2023) Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. Journal of Pharmaceutical and Biological Sciences 11:1, pages 18-25.
Crossref
Crossref
. 2023. Laboratory Animal Anaesthesia and Analgesia. Laboratory Animal Anaesthesia and Analgesia
295
335
.
Paul Flecknell. 2023. Laboratory Animal Anaesthesia and Analgesia. Laboratory Animal Anaesthesia and Analgesia
51
90
.
Amanda C. Peltier. 2022. Diabetic Neuropathy. Diabetic Neuropathy
299
311
.
L. Brullot, G. Hans, P.J. Germonpré, D. Mesotten, T. Vanneste & K. Van Boxem. (2021) Retrospectieve praktijkanalyse van tapentadol met vertraagde afgifte bij patiënten met chronische pijn refractair aan sterke opioïden. Tijdschrift voor Geneeskunde.
Crossref
Crossref
Muhammad Zaeem Ahsan, Farhan Ullah Khan, Meng-Jing Zhao & Yong-Xiang Wang. (2020) Synergistic interaction between butorphanol and dexmedetomidine in antinociception. European Journal of Pharmaceutical Sciences 149, pages 105322.
Crossref
Crossref
Robert A. SwarmJudith A. PaiceDoralina L. AnghelescuMadhuri AreJustine Yang BruceSorin BugaMarcin ChwistekCharles CleelandDavid CraigEllin GaffordHeather GreenleeEric HansenArif H. KamalMihir M. KamdarSusan LeGrandSean MackeyM. Rachel McDowellNatalie MorylLisle M. NabellSuzanne Nesbit, Nina O’ConnorMichael W. RabowElizabeth RickersonRebecca ShatskyJill SindtSusan G. UrbaJeanie M. Youngwerth, Lydia J. Hammond & Lisa A. Gurski. (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:8, pages 977-1007.
Crossref
Crossref
Yingchao Li, Yongjun Wang, Ran Zhang, Cuiru Liu, Yue Wei, Jin Sun, Zhonggui He, Youjun Xu & Tianhong Zhang. (2018) Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics. Drug Delivery and Translational Research 8:5, pages 1335-1344.
Crossref
Crossref
Seema Gupta, Nusrat Kreem Bhat, Shivani Rani, Farid Hussain & Rajesh Kumar. (2018) COMPARATIVE EFFICACY AND SAFETY OF TAPENTADOL AND TRAMADOL IN PATIENTS WITH MODERATE TO SEVERE CHRONIC LOW BACK PAIN: A PROSPECTIVE, RANDOMIZED, OPEN-LABELTRIAL AT TERTIARY CARE TEACHING HOSPITAL IN NORTH INDIA. Journal of Evidence Based Medicine and Healthcare 5:6, pages 542-548.
Crossref
Crossref
O. Gunduz, R.D. Topuz, C.H. Karadag & A. Ulugol. (2016) Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice. European Journal of Pain 20:3, pages 465-471.
Crossref
Crossref
. 2016. Laboratory Animal Anaesthesia. Laboratory Animal Anaesthesia
273
311
.
Lingjuan Xiong, Rong Wang, Chen Liang, Xiaomei Teng, Fengli Jiang, Libo Zeng, Haiying Ye, Chunfang Ni, Xiaoliang Yuan, Yulan Rao & Yurong Zhang. (2015) Determination of co-administrated opioids and benzodiazepines in urine using column-switching solid-phase extraction and liquid chromatography–tandem mass spectrometry. Journal of Chromatography A 1395, pages 99-108.
Crossref
Crossref
William W. MuirIIIIII. 2015. Handbook of Veterinary Pain Management. Handbook of Veterinary Pain Management
113
141
.
Marco Sisignano, Ralf Baron, Klaus Scholich & Gerd Geisslinger. (2014) Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nature Reviews Neurology 10:12, pages 694-707.
Crossref
Crossref
Vasco Meneghini, Bruna Cuccurazzu, Valeria Bortolotto, Vera Ramazzotti, Federica Ubezio, Thomas M. Tzschentke, Pier Luigi Canonico & Mariagrazia Grilli. (2014)
The Noradrenergic Component in Tapentadol Action Counteracts
μ
-Opioid Receptor–Mediated Adverse Effects on Adult Neurogenesis
. Molecular Pharmacology 85:5, pages 658-670.
Crossref
Crossref
Joost L. M. Jongen, Guy Hans, Honorio T. Benzon, Frank Huygen & Craig T. Hartrick. (2014) Neuropathic Pain and Pharmacological Treatment. Pain Practice 14:3, pages 283-295.
Crossref
Crossref
Mana SaraghiElliot V. Hersh. (2013) Three Newly Approved Analgesics: An Update. Anesthesia Progress 60:4, pages 178-187.
Crossref
Crossref